共 5 条
[3]
Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele. Xiao Z S, Goldstein J A, Xie H G, et al. Journal of Pharmacology and Experimental Therapeutics . 1997
[4]
Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6. Wang SL, Huang JD, Lai MD, et al. Clinical Pharmacokinetics . 1993
[5]
Genetic analysis of the S-mephenytoin polymorphism in a Chinese population. de Morais S M F, Goldstein J A, Xie H G, et al. Clinical Pharmacokinetics . 1995